A Prospective Analysis of the Effect of Therapeutic Hypothermia After Cardiac Arrest
1 other identifier
observational
70
1 country
1
Brief Summary
Therapeutic hypothermia has been shown to improve survival and neurologic outcome in patients resuscitated after ventricular fibrillation arrest. Few studies have examined whether therapeutic hypothermia is effective outside the research setting, or with other presenting rhythms. Our institution, a large community teaching hospital, instituted a therapeutic hypothermia protocol in November 2006 for all resuscitated cardiac arrest patients. The investigators seek to determine the mortality rate of our protocol and compare our complication rates with those of previously published studies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2007
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2007
CompletedFirst Submitted
Initial submission to the registry
May 12, 2008
CompletedFirst Posted
Study publicly available on registry
May 13, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedJanuary 6, 2012
January 1, 2012
3 years
May 12, 2008
January 4, 2012
Conditions
Keywords
Eligibility Criteria
Any adult non-pregnant patient who is unresponsive after resuscitation from cardiac arrest regardless of presenting rhythm and who survives to hospital admission.
You may qualify if:
- Any adult non-pregnant patient who is unresponsive after resuscitation from cardiac arrest regardless of presenting rhythm and who survives to hospital admission.
You may not qualify if:
- hypotension (SBP \<90), initial temperature \< 30 °C, trauma, primary intracranial event, or active coagulopathy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Adcovate Christ Hospital
Oak Lawn, Illinois, 60453, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Erik B Kulstad, MD,MS
advocate christ medical center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Attending Physician
Study Record Dates
First Submitted
May 12, 2008
First Posted
May 13, 2008
Study Start
January 1, 2007
Primary Completion
January 1, 2010
Study Completion
December 1, 2010
Last Updated
January 6, 2012
Record last verified: 2012-01